Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial

INTRODUCTION: The Strategic Timing of AntiRetroviral Treatment (START) trial has recruited antiretroviral-naïve individuals with high CD4 cell counts from all world regions. We describe the distribution of cardiovascular (CVD) risk factors, overall and by geographic region, at study baseline. METHOD...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:HIV Med
Prif Awduron: Soliman, Elsayed Z., Sharma, Shweta, Arastéh, Keikawus, Wohl, David, Achhra, Amit, Tambussi, Giuseppe, O’Connor, Jemma, Stein, James H., Duprez, Daniel A., Neaton, James D., Phillips, Andrew
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4341949/
https://ncbi.nlm.nih.gov/pubmed/25711323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12233
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg